Deepcell Information, Including Revenue, Investors, Funding, Competitors & Key Metrics

Deepcell provides software for single-cell dimensional morphology analysis. They also provide an AI-powered imaging and microfluidics platform that identifies and isolates viable cells based on morphological distinctions for use in translational research, diagnostic testing, and therapeutics.

Repeat Founder
Elite School Alumni
Top 100 in Genetics
Top 100 in Genetics in United States
Company Highlights
Year Founded

2017

icon-altEmployees

44

Location (HQ)

USA

Since Last Funding

2 years 7 months

Monthly Website Visitors

7.2K

icon-altTotal Investment Amt

$98M

Last Funding Round

Series B

icon-altYoY Headcount Growth

-59.2%

Key Metrics

Senior Hires

NameLinkedin ProfilePositionDate Joined
John Doehttps://www.linkedin.com/in/johndoeCEOCEO
Jane Doehttps://www.linkedin.com/in/janedoeCTOCTO
John Smithhttps://www.linkedin.com/in/johnsmithCFOCFO
Jane Smithhttps://www.linkedin.com/in/janesmithCOOCOO
Get API access to complete private company database with growth metrics from 15 sources

Similar Companies

Biotechnology

Health Care

Biotechnology Research

Genetics